Indications and uses
temporarily: • reduces fever • relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches
Walgreen Co. Ibuprofen Concentrated Drops Drug Facts
- Manufacturer
- Walgreen Company
- Effective date
- 2019-12-03
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:56:13
Label at a glance#
Productibuprofen
Active ingredientIBUPROFEN
Label structure9 sections
Dosage and administration
• this product does not contain directions or complete warnings for adult use • do not give more than directed • do not give longer than 10 days, unless directed by a doctor (see Warnings) • shake well before using • find right dose on chart below. If possible, use weight to dose; otherwise use age. • measure with the dosing device provided. Do not use with any other device. • dispense liquid slowly into the child...
Storage and handling
• do not use if printed neckband is broken or missing • store at 20-25°C (68-77°F) • see bottom of box for lot number and expiration date
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient (in each 1.25 mL)
Ibuprofen 50 mg (NSAID)*
*nonsteroidal anti-inflammatory drug
Purpose
Pain reliever/fever reducer
Uses
temporarily:
- reduces fever
- relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches
Warnings
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
- hives
- facial swelling
- asthma (wheezing)
- shock
- skin reddening
- rash
- blisters
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding.
The chance is higher if the child
- has had stomach ulcers or bleeding problems
- takes a blood thinning (anticoagulant) or steroid drug
- takes other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others]
- takes more or for a longer time than directed
Sore throat warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by doctor.
Do not use
- if the child has ever had an allergic reaction to any other pain reliever/fever reducer
- right before or after heart surgery
Ask a doctor before use if
- the stomach bleeding warning applies to your child
- child has a history of stomach problems, such as heartburn
- child has not been drinking fluids
- child has lost a lot of fluid due to vomiting or diarrhea
- child has high blood pressure, heart disease, liver cirrhosis, or kidney disease
- child has asthma
- child is taking a diuretic
Ask a doctor or pharmacist before use if the child is
- under a doctor’s care for any serious condition
- taking any other drug
When using this product
- give with food or milk if stomach upset occurs
- the risk of heart attack or stroke may increase if you use more than directed or for longer than directed
Stop use and ask a doctor if
- child experiences any of the following signs of stomach bleeding:
- feels faint
- vomits blood
- has bloody or black stools
- has stomach pain that does not get better
- the child does not get any relief within first day (24 hours) of treatment
- fever or pain gets worse or lasts more than 3 days
- redness or swelling is present in the painful area
- any new symptoms appear
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Directions
- this product does not contain directions or complete warnings for adult use
- do not give more than directed
- do not give longer than 10 days, unless directed by a doctor (see Warnings)
- shake well before using
- find right dose on chart below. If possible, use weight to dose; otherwise use age.
- measure with the dosing device provided. Do not use with any other device.
- dispense liquid slowly into the child’s mouth, toward the inner cheek
- if needed, repeat dose every 6-8 hours
- do not use more than 4 times a day
Dosing Chart | ||
Weight (lb) | Age (mos) | Dose (mL) |
under 6 mos | ask a doctor | |
12-17 lbs | 6-11 mos | 1.25 mL |
18-23 lbs | 12-23 mos | 1.875 mL |
Other information
- do not use if printed neckband is broken or missing
- store at 20-25°C (68-77°F)
- see bottom of box for lot number and expiration date
SPL UNCLASSIFIED SECTION
Inactive ingredients
anhydrous citric acid, butylparaben, flavor, glycerin, hypromellose, polysorbate 80, propylene glycol, purified water, sodium benzoate, sorbitol solution, sucrose, xanthan gum
Questions or comments?
1-800-719-9260
Principal Display Panel
Compare to Motrin® Infants' Drops active ingredient
SEE NEW WARNINGS INFORMATION
For Ages 6 Mos. -23 Mos.
Infants'
IBUPROFEN CONCENTRATED DROPS
Ibuprofen Oral Suspension
50 mg per 1.25 mL
Pain Reliever/Fever Reducer (NSAID)
Dye-Free
Lasts Up to 8 Hours
Alcohol Free
Non-Staining
BERRY FLAVOR
Use only with enclosed syringe
Ibuprofen Concentrated Drops Carton Image 2
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-0255-10 | ML - Milliliter | 0363-0255 | 590cf971-a017-49f3-a3bd-1d8db552c4e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 1 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 1 |
Products#
Every source-derived product name is available through these pages.
- ibuprofen
- ANHYDROUS CITRIC ACID
- BUTYLPARABEN
- GLYCERIN
- HYPROMELLOSE, UNSPECIFIED
- POLYSORBATE 80
- PROPYLENE GLYCOL
- WATER
- SODIUM BENZOATE
- SORBITOL
- SUCROSE
- XANTHAN GUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0363-0255 | 0363-0255-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IBUPROFEN | WK2XYI10QM | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| BUTYLPARABEN | 3QPI1U3FV8 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SORBITOL | 506T60A25R | IACT |
| SUCROSE | C151H8M554 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075217-001 | IBUPROFEN | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A075217-001 | IBUPROFEN | 40MG/ML | SUSPENSION/DROPS / ORAL | 1998-12-16 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 259be450-a314-4120-a028-34292058b771 | e8541364-d649-42e9-9e41-e3201ba10433 | 2021-11-03 | Warnings | e8541364-d649-42e9-9e41-e3201ba10433 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.